Inventor · disambiguated record
Glenn E. Nedwin
Also filed as: NEDWIN GLENN · NEDWIN GLENN E
12 granted patents·98 citations·filing 1992–2013
90Inventor score
Top patents by PatentIndex Score
12 records- 0190US8815560B2Alpha-amylase blend for starch processing and method of use thereofDANISCO US INC·Filed 2013·Granted Aug 26, 2014·2 cites·35 claims
- 0289US6245334B1Method of causing selective immunosuppression using HL-60-related lectinsINCYTE PHARMA INC·Filed 2000·Granted Jun 12, 2001·35 cites·8 claims
- 0383US8545907B2Alpha-amylase blend for starch processing and method of use thereofNEDWIN GLENN E·Filed 2010·Granted Oct 1, 2013·2 cites·35 claims
- 0474US5824509ARecombinant lymphotoxin cDNA and variantsGENENTECH INC·Filed 1995·Granted Oct 20, 1998·19 cites·20 claims
- 0553US5693760AMethod of causing selective immunosuppression using HL-60 related lectinsINCYTE PHARMA INC·Filed 1994·Granted Dec 2, 1997·13 cites·12 claims
- 0651US5683688AUnglycosylated recombinant human lymphotoxin polypeptides and compositionsGENENTECH INC·Filed 1992·Granted Nov 4, 1997·7 cites·23 claims
- 0746US5587460A14-beta-gal mammalian lectinsINCYTE PHARMACEUTICAL CORP·Filed 1994·Granted Dec 24, 1996·11 cites·1 claims
- 0843US6177543B1Recombinant lymphotoxinGENENTECH INC·Filed 1998·Granted Jan 23, 2001·2 cites·9 claims
- 0943US5710257AMethod of causing selective immunosuppression using HL-60-related lectinsFiled 1996·Granted Jan 20, 1998·6 cites·8 claims
- 1034US5633148AUnique lectinsINCYTE PHARMA INC·Filed 1995·Granted May 27, 1997·1 cites·7 claims
- 1130US6153195AMethod of delivering drugs to cells specific for an HL-60 lectinINCYTE PHARMA INC·Filed 1996·Granted Nov 28, 2000·0 cites·2 claims
- 1226US6406679B1Use of HL-60-related lectins in drug delivery and detection of lectin-expressing cellsINCYTE PHARMA INC·Filed 1996·Granted Jun 18, 2002·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Glenn E. Nedwin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →